Technology Transfer for Biotech: From University Laboratories to New Companies
Date: September 6th 8pm – 9pm EDT
Format: Online vs Onsite(invitation only)
Registration Link:
Discover the driving force behind the dynamic biotech landscape at our seminar. Unveiling the blueprint for success, we delve into the pivotal role of university research in birthing groundbreaking biotech ventures. With a significant proportion of emerging biotech companies tracing their roots back to cutting-edge university discoveries fueled by Federal funding, the seminar illuminates the transformative journey of ideas from academia to the marketplace.
The majority of new biotech companies originate with new discoveries and inventions from university research, most of which was sponsored by Federal funding. Patents from such research are owned by the universities, and rights to them are given to new startups via licensed granted by the university.
This seminar discusses how MIT manages patent filings and licensing through its Technology Licensing Office, and encourages entrepreneurship by faculty and students through its many “Innovation” initiatives. Hundreds of new biotech companies have spun out of MIT and its Whitehead Institute affiliate. Some of the more famous local companies include Alnylam, BluebirdBio, Momenta, and Ginko Bioworks.
Lita Nelsen retired after over 25 years as Director of MIT’s Technology Licensing Office. She is now a consultant or board member to several new biotech companies and a mentor in MIT’s Sandbox student entrepreneurship program and an advisor to GoodGrowth Capital, an early stage venture capital company. She is also a lecturer (via Zoom) in technology licensing for Hong Kong University.
Whether you’re a budding entrepreneur, an academic luminary, or an industry aficionado, this seminar promises unparalleled insights into the art of translating revolutionary biotech concepts into real-world success stories. Join us in unraveling the secrets behind MIT’s triumphant technology transfer saga and learn how you, too, can be a part of the vanguard shaping the future of biotech innovation. Don’t miss this opportunity to ignite your passion and drive innovation forward at the nexus of academia and industry.
Boston Chinese Investment Club
Boston Chinese Investment Club (BCIC) is a non-profit organization founded in 2010 with more 7000 professionals in Finance, Venture Capital, and various technology industries. It serves as Boston centered platform for exchanging ideas, knowledge, and information in finance and related areas between US and China. Main activities include summits, conferences, and seminars. If you want to join us, please send email to boston.chinese.investment.club@gmail.com. If you are interested in participating future road shows, please contact us in advance: start ups please send business plans to roadshow@bcicglobal.org; investors or sponsors, please contact info@bcicglobal.org.
【BCIC Sponsors】
E Fund Management Co., LTD.
(http://www.efunds.com.cn/html/menu/2.htm/)
Global Asset Management
(https://www.haitouglobal.com/)
Quantitative Asset Management
U.S. & International Tax and Legal Services
Shanghai Zhangjiang Boston Enterprise Park
(http://www.zjbostonpark.com/)
JJLake Asian Future Innovation Challenge Boston Chapter
Hong Kong Science and Technology Parks Corporation
Early stage capital for startups in Healthcare and Consumption
My Visa Services
https://www.myvisaservices.com/home-en
Boston Chinese Investment Club (BCIC) is a non-profit organization founded in 2010 with more 6000 professionals in Finance, Venture Capital, and various technology industries. It serves as a Boston centered platform for exchanging ideas, knowledge, and information in finance and related areas between US and China. Main activities include summits, conferences, and seminars. （https://bcicglobal.org/）
